These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 25037561)
1. Protein carbamylation in kidney disease: pathogenesis and clinical implications. Kalim S; Karumanchi SA; Thadhani RI; Berg AH Am J Kidney Dis; 2014 Nov; 64(5):793-803. PubMed ID: 25037561 [TBL] [Abstract][Full Text] [Related]
2. Protein Carbamylation in Chronic Kidney Disease and Dialysis. Long J; Vela Parada X; Kalim S Adv Clin Chem; 2018; 87():37-67. PubMed ID: 30342712 [TBL] [Abstract][Full Text] [Related]
3. Role of Carbamylated Biomolecules in Human Diseases. Badar A; Arif Z; Alam K IUBMB Life; 2018 Apr; 70(4):267-275. PubMed ID: 29542227 [TBL] [Abstract][Full Text] [Related]
4. Carbamylation-derived products: bioactive compounds and potential biomarkers in chronic renal failure and atherosclerosis. Jaisson S; Pietrement C; Gillery P Clin Chem; 2011 Nov; 57(11):1499-505. PubMed ID: 21768218 [TBL] [Abstract][Full Text] [Related]
5. Protein carbamylation in end stage renal disease: is there a mortality effect? Kalim S Curr Opin Nephrol Hypertens; 2018 Nov; 27(6):454-462. PubMed ID: 30148723 [TBL] [Abstract][Full Text] [Related]
6. [The value of a low-protein diet and ketoanalogues of essential amino acids in the сontrol of protein carbamylation and toxic effects of urea in chronic kidney disease]. Mikhailova NA Ter Arkh; 2021 Jun; 93(6):729-735. PubMed ID: 36286841 [TBL] [Abstract][Full Text] [Related]
7. Protein Carbamylation and the Risk of ESKD in Patients with CKD. Kalim S; Zhao S; Tang M; Rhee EP; Allegretti AS; Nigwekar S; Karumanchi SA; Lash JP; Berg AH J Am Soc Nephrol; 2023 May; 34(5):876-885. PubMed ID: 36757153 [TBL] [Abstract][Full Text] [Related]
8. Carbamylated Proteins in Renal Disease: Aggravating Factors or Just Biomarkers? Gorisse L; Jaisson S; Piétrement C; Gillery P Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008998 [TBL] [Abstract][Full Text] [Related]
9. Longitudinal Changes in Protein Carbamylation and Mortality Risk after Initiation of Hemodialysis. Kalim S; Trottier CA; Wenger JB; Wibecan J; Ahmed R; Ankers E; Karumanchi SA; Thadhani R; Berg AH Clin J Am Soc Nephrol; 2016 Oct; 11(10):1809-1816. PubMed ID: 27445162 [TBL] [Abstract][Full Text] [Related]
10. [Carbamylation of proteins--mechanism, causes and consequences]. Pieniążek A; Gwoździński K Postepy Hig Med Dosw (Online); 2016 May; 70():514-21. PubMed ID: 27180968 [TBL] [Abstract][Full Text] [Related]
11. Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies. Shi J; van Veelen PA; Mahler M; Janssen GM; Drijfhout JW; Huizinga TW; Toes RE; Trouw LA Autoimmun Rev; 2014 Mar; 13(3):225-30. PubMed ID: 24176675 [TBL] [Abstract][Full Text] [Related]
12. Carbamylation of proteins and sulfacetamide free fraction in serum in experimentally-induced high blood urea states. Erill S; du Souich P; Courteau H Res Commun Chem Pathol Pharmacol; 1985 Oct; 50(1):45-56. PubMed ID: 4081313 [TBL] [Abstract][Full Text] [Related]
13. Impaired biological activity of erythropoietin by cyanate carbamylation. Mun KC; Golper TA Blood Purif; 2000; 18(1):13-7. PubMed ID: 10686438 [TBL] [Abstract][Full Text] [Related]